In February 2026, NAFDAC officers acting on intelligence from a training exercise raided a cluster of warehouses near the Trade Fair complex in Lagos. The buildings were disguised as residential structures. Inside, stacked in eight fully loaded trailers worth of cartons, officers found more than ten million doses of counterfeit and banned medicines: fake injectable antimalarials, fake antibiotics, fake sachet medicines, and fake blister-packaged drugs designed to be indistinguishable from the genuine products they were imitating.
NAFDAC's Director of Investigation and Enforcement, Martins Iluyomade, said the bust followed actionable intelligence generated during a security and enforcement meeting held on February 3 which flagged suspicious movements around the Trade Fair area. In many cases, even the original manufacturers struggle to differentiate the counterfeits from genuine products. That is how advanced these criminal networks have become. The estimated street value of the seized drugs exceeds three billion naira. Eight truckloads of assorted fake medicines and cosmetics were evacuated from the warehouses during the operation.
Eight truckloads. Ten million doses. A single operation in a single city.
A month later, in March 2026, NAFDAC supervised the destruction of another batch of seized products at the Anambra State Waste Management dumpsite in Awka. The Director General of NAFDAC, Prof. Christianah Adeyeye, said it was a decisive regulatory action aimed at removing unsafe, substandard, falsified, and expired products from the market. The products destroyed included expired, substandard, and falsified medicines, as well as unregistered pharmaceuticals, food, medical equipment, and cosmetics. Their estimated street value was 939 million naira.
These are not exceptional events. They are the routine rhythm of Nigeria's public health emergency. NAFDAC has destroyed illicit drugs valued at over one trillion naira in intensified nationwide enforcement against substandard, falsified, and dangerous products, leading to mass arrests and prosecutions. The scale underscores the magnitude and severity of the proliferation of counterfeit drugs and unwholesome foods in the country and its cataclysmic effects on Nigerians and the nation's pharmaceutical industry.
A trillion naira. Destroyed. And the supply continues.
This article is about what you need to know to protect yourself, your family, and your community from a crisis that NAFDAC is fighting aggressively but that requires every Nigerian to become a participant in their own protection.
The Scale That Should Alarm Every Nigerian
The numbers that describe Nigeria's fake drug crisis are so large that they risk losing their impact. Hundreds of millions here. Billions there. Tens of billions in a single raid. One trillion over a year of enforcement. When figures reach this scale, they stop feeling concrete and start feeling abstract. The purpose of this section is to translate the abstract back into the concrete: what these numbers mean for human lives.
Poor quality antimalarials are responsible for an estimated 12,300 deaths and 892 million dollars in costs annually in Nigeria alone. The northern regions of Nigeria have a greater burden compared to the southern regions, with 9,700 deaths and 698 million dollars in total economic losses annually due to substandard and falsified antimalarials.
12,300 people. Every year. Killed not by malaria, which is treatable with effective medicine, but by the fake versions of the treatment they took believing they were being protected. These are not deaths from lack of access to treatment. They are deaths from treatment that failed because the product in the packet was not what it claimed to be.
A recent study by the UN Office on Drugs and Crime reveals that up to 500,000 people die annually from counterfeit drugs in sub-Saharan Africa. Medical experts are deeply concerned about the impact of fake drugs on the health of Nigerians, stressing that counterfeit medications increase deaths from malaria, stroke, hypertension, asthma, cholera, and other illnesses prevalent in the country. In some cases, patients struggle to respond to genuine medications after prior continuous intake of counterfeit antibiotics and medical supplements.
This last point deserves to be isolated and read clearly. Fake antibiotics do not merely fail to treat the infection they claim to treat. They train the bacteria in the patient's body to resist the antibiotic. When the patient subsequently receives a genuine, properly dosed antibiotic, the bacteria may already have developed resistance to it. The fake drug has not just failed to cure the disease. It has actively made the disease harder to cure.
In Nigeria, NAFDAC revealed that 30 percent of drugs in open markets were fake or substandard. Then, in March 2025, the agency seized and destroyed a staggering one trillion naira worth of confiscated drugs, including banned Analgin and lethal high-dose Tramadol at 225 milligrams, after a sweeping operation across the notorious drug markets in Onitsha and Aba. This raid is only the latest chapter in NAFDAC's tireless crackdown. The World Health Organisation's report on substandard and falsified medical products delivers a damning verdict: at least one in ten medicines in low and middle-income countries is substandard or falsified. These killer products, sold online or in informal markets, cost countries an estimated 30.5 billion dollars every year.
Thirty percent of drugs in open markets. In a country where millions of people buy their medicines from open markets because licensed pharmacies are inconvenient, expensive, or simply absent from their communities, that figure is not a statistical abstraction. It is a direct statement that approximately one in three purchases from an open-market drug vendor in Nigeria involves a product that may not work as labelled, may contain harmful ingredients, may be expired, or may be entirely counterfeit.
How the Fake Drug Trade Actually Works: Following the Chain
Understanding why this crisis persists, despite billions of naira in enforcement activity, requires understanding the specific mechanisms through which fake and expired drugs enter the Nigerian market and reach Nigerian consumers. The trade is not random. It is organised, sophisticated, and in some cases impossible to distinguish from the legitimate pharmaceutical supply chain at the point of purchase.
Repackaging and Date Alteration Syndicates
The most well-documented and most disturbing mechanism is the repackaging syndicate. In December 2024, NAFDAC identified Eziukwu Market, also known as Cemetery Market, in Aba, Abia State, as a major hub for the production and distribution of fake and substandard products, following a targeted enforcement operation.
The Aba operations revealed industrial-scale repackaging facilities where expired drugs were processed, given new expiry dates printed with professional equipment, and repackaged in materials that closely mimicked legitimate pharmaceutical packaging. Items seized included potassium chloride, allergy medications, immune boosters, and cholesterol treatments. The criminals operating these facilities were not street vendors selling visibly damaged goods. They were running what amounted to a counterfeit pharmaceutical manufacturing operation with equipment sophisticated enough to defeat casual inspection.
The specific crime of altering expiry dates is particularly dangerous because it combines two distinct harms. The altered drug may be genuinely expired, meaning its active ingredients have degraded to the point where it provides no therapeutic benefit. But some expired drugs degrade into compounds that are actively toxic, meaning the patient is not simply receiving an ineffective treatment. They are receiving a harmful one. Tetracycline antibiotics, for example, can become nephrotoxic when expired. Aspirin can break down into compounds that cause stomach damage. The expired drug is not a neutral non-event. It can be an active threat.
Smuggled and Diverted Stock
The second major entry mechanism involves drugs that were legitimately manufactured and shipped but diverted from authorised distribution channels before reaching properly licensed outlets. Nigeria's heavy dependence on imports, with about 70 percent of medicines coming from India, China, Pakistan, Egypt, and Indonesia, creates multiple vulnerabilities in the supply chain from manufacture to pharmacy shelf.
A consignment of genuine medicine that is diverted at the port, stored in uncontrolled conditions that accelerate degradation, then relabelled and sold through informal channels, is simultaneously a genuine product and a dangerous one. The active ingredient may have degraded in storage. The cold chain for temperature-sensitive medicines may have been broken. The patient and even the pharmacist who dispenses it have no way of knowing, from visual inspection of a legitimately manufactured package, that the medicine inside it has been compromised.
Unregistered Imports and Online Markets
According to NAFDAC, fake medicines seized in recent operations were difficult to identify even by manufacturers, because they were designed to closely resemble genuine products.
Online drug sales represent a growing and particularly dangerous frontier in the fake drug ecosystem. The same digital channels that have democratised access to commerce have democratised access to the fake drug supply chain. A consumer buying medication online cannot physically inspect the product, cannot verify the credentials of the seller, and cannot verify the storage history of the medicine. NAFDAC has issued repeated warnings about online drug vendors, but enforcement in digital spaces is structurally more difficult than enforcement in physical markets.
The Human Face: What These Drugs Do to Real People
Morayo's left eye is now completely shut. She was later diagnosed with acute glaucoma after using eye drops she bought from a neighbourhood chemist. When she went back to challenge the chemist, he denied selling the drops to her. It was clearly a fake drug.
Morayo's story is one of thousands. The victims of Nigeria's fake drug crisis are not statistical categories. They are parents who gave their children antimalarials that did not work, watching fever climb despite treatment. They are patients who took antibiotics for infections that persisted because the drugs contained insufficient active ingredient. They are people with chronic conditions like hypertension and diabetes whose disease progressed because the medication managing their condition was substandard.
NAFDAC warned that the presence of fake emergency medicines poses a serious risk to public health. Counterfeit injections used to treat severe conditions such as cerebral malaria could lead to death if administered to patients. When fake medicines are used in such cases, the consequences can be fatal.
Cerebral malaria is one of the most time-sensitive medical emergencies in Nigerian hospitals. A patient presenting with cerebral malaria needs a correct dose of an effective antimalarial drug administered immediately. A fake injection in that moment is not merely ineffective. It is a death sentence delivered in a clinical setting by a healthcare worker who has no idea the medicine they are administering is counterfeit.
Prices for medical products such as inhalers have now more than doubled in a country where about ten million people have asthma, driving up demand for fake drugs. A recent move by two pharma giants, GSK and Sanofi, to end operations in Nigeria, has made legitimate medical products even scarcer and more expensive.
The departure of major international pharmaceutical manufacturers from Nigeria creates exactly the price and availability environment in which fake drugs thrive. When genuine medicines are expensive or unavailable, the market for cheaper substitutes expands. The economic conditions that drive people toward open-market drug vendors rather than licensed pharmacies are the same conditions that make them vulnerable to counterfeit products.
Where the Raids Have Hit and What They Found
The pattern of NAFDAC raids across 2025 and into 2026 reveals the geographic spread and specific character of Nigeria's fake drug ecosystem.
Lagos, February 2026: More than ten million doses of counterfeit and banned medicines including injectable antimalarials, antibiotics, sachet medicines, and blister-packaged drugs were seized in warehouses near the Trade Fair complex. Eight trailers of seized goods were removed. Estimated street value exceeded ten billion naira.
Awka, Anambra, March 2026: Products with a total estimated street value of 939,077,209 naira were destroyed. The seized items, recovered from across the South-East, included expired, substandard, and falsified medicines. NAFDAC's Director General stated that these products pose serious health risks to consumers, including treatment failure, prolonged illness, and even death.
Aba, Abia State: The Ariaria International Market area and surrounding communities have been the site of repeated enforcement operations targeting industrial-scale repackaging facilities. Seized items included potassium chloride, allergy medications, immune boosters, and cholesterol treatments, all with altered expiry dates.
Onitsha and Aba, March 2025: A sweeping operation across the notorious drug markets in Onitsha and Aba resulted in the seizure and destruction of approximately one trillion naira worth of confiscated drugs, including banned Analgin and lethal high-dose Tramadol at 225 milligrams.
Ibadan and South-West Zone: Multiple exercises across late 2025 and into 2026 resulted in the destruction of products collectively valued in the tens of billions.
NAFDAC announced the destruction of over 80 containers of fake and substandard medicines and food items as part of its ongoing nationwide enforcement campaign. The Director of Investigation and Enforcement said, the moral decadence in Nigeria is alarming, and many people benefit from this illicit trade. We will continue to mop up these markets and reduce the level of substandard products to the barest minimum.
The geographic pattern reveals that the fake drug trade is not concentrated in one region or one type of market. It operates from major commercial hubs like Lagos and Onitsha through to smaller regional markets in the South-East and beyond. It involves industrial-scale repackaging operations in Aba, distribution networks through open markets like Ariaria and Idumota, and sophisticated warehouse operations in Lagos that operated undetected in what appeared to be residential areas.
NAFDAC's Public Alerts: Specific Products Flagged in 2026
Beyond the large-scale destruction exercises, NAFDAC has issued specific public alerts about named counterfeit products that may still be in circulation.
Public Alert No. 01/2026 on TAVANIC 500mg Tablets: NAFDAC issued a formal alert on the sale of falsified TAVANIC 500mg tablets in Nigeria. The counterfeit product was labelled with genuine batch details, making it difficult to distinguish from authentic stock. Trace investigations revealed the fake products were produced from expired stock. TAVANIC is a fluoroquinolone antibiotic used for serious bacterial infections. A patient taking a counterfeit TAVANIC for a severe infection, believing they are receiving an effective antibiotic, may not only fail to recover but may deteriorate to a point requiring hospitalisation or resulting in death.
Fake Proguanil Tablets: NAFDAC has issued alerts on falsified proguanil, an antimalarial used both for treatment and for prophylaxis by travellers and high-risk individuals. A person taking fake proguanil believing they are protected against malaria is entirely unprotected. If they are in a high-transmission environment and rely on that protection, they are at significant risk of infection.
These specific alerts illustrate a feature of the fake drug trade that general enforcement statistics do not capture: the criminal networks are specifically targeting medicines for serious, potentially fatal conditions where the patient's reliance on the treatment is absolute. Counterfeit antimalarials, antibiotics, and cardiovascular medications are more dangerous to produce and sell than counterfeit vitamins or cosmetics, but they command higher prices and have larger, more desperate markets.
How to Protect Yourself: A Practical Guide to Verifying Medicines
The most important thing any Nigerian can do in response to the fake drug crisis is adopt specific verification practices for every medicine purchased. These are not complicated steps. They require awareness and a minute of attention, but they can save your life or the life of someone in your family.
1. Check the NAFDAC Registration Number
Every legitimately approved product in Nigeria must carry a NAFDAC registration number on its packaging. This is not merely a formality. It is a trackable identifier that you can verify. Many medicines have a scratch panel on the packaging that conceals a PIN. Scratching this panel and sending the PIN via SMS to NAFDAC's short code service allows you to verify whether the product is genuine in real time.
The NAFDAC Greenbook app, available on both Google Play and the Apple Store, provides another digital verification pathway. Enter the registration number or scan the packaging code and the app confirms whether the product is registered and whether the specific batch details match the registered product.
2. Assess Packaging Quality
Genuine pharmaceutical packaging is produced to consistent, high-quality standards. Sharp printing, correct colours, properly aligned text, and no spelling errors are the baseline. Fake packaging is often produced on equipment that cannot match these standards. Blurry printing, colour inconsistencies, typographical errors, and text that does not align correctly are red flags. Hold the package under good light and compare the quality with other packs of the same product if you have seen them before.
3. Check Seals and Tamper Evidence
A broken seal on a medicine you have purchased new is an immediate disqualifying indicator. Do not use the product. Return it to the seller if you can, but more importantly, report it to NAFDAC. Double seals, seals that do not fit properly, or seals that show signs of having been removed and replaced are equally concerning.
4. Read the Expiry Date Carefully
The specific fraud of altered expiry dates is detectable if you look carefully. Numbers that appear to have been printed over other numbers, ink that does not match the rest of the packaging, or dates that appear slightly different in font, size, or spacing from the surrounding text may indicate alteration. On tablets and capsules, if the date on the blister card does not match the date on the outer box, something is wrong.
5. Be Suspicious of Anomalous Pricing
Legitimate pharmaceutical products have market prices that are reasonably consistent across licensed outlets. A medicine being sold significantly below the going rate is a warning sign, not a bargain. The economics of the fake drug trade require that products be priced attractively enough to compete with genuine medicines, which means counterfeits are often cheap. If a price seems too good to be true for a medicine you know to be expensive, treat that suspicion seriously.
6. Buy Only From Licensed Sources
This is the single most important structural decision you can make to protect yourself from fake drugs. NAFDAC has advised Nigerians to buy only products with valid NAFDAC registration numbers and to report suspicious items or activities. Licensed pharmacies are registered with the Pharmacists Council of Nigeria, operating under regulatory oversight that creates at least the structural incentive to stock genuine products. Open markets, street vendors, unlicensed chemists operating from market stalls, and unverified online sellers operate outside this oversight.
The practical reality is that licensed pharmacies are more expensive than open-market vendors and may be less accessible in some communities. This is a genuine tension. But the cost of a fake medicine is not the purchase price. It is the cost of the treatment failure, the extended illness, the hospitalisation, the drug resistance, or the death that the fake medicine either causes or allows to proceed untreated. Measured against these costs, the premium price of a licensed pharmacy is not a luxury. It is an investment in the probability that the medicine you purchase will do what it is supposed to do.
7. Inspect the Physical Tablet or Capsule
If you have reason to be uncertain about a product after purchasing it, examine the tablets or capsules before taking them. Genuine tablets are produced in consistent batches with uniform size, shape, colour, and markings. Tablets that vary significantly in these characteristics within the same packet, that crumble easily in a way that suggests improper composition, or that have colour variations inconsistent with what you expect from the product are warning signs.
8. Report Suspicious Products
NAFDAC cannot be everywhere simultaneously. Its enforcement capacity, however substantial it has become, cannot substitute for a vigilant public that reports suspicious products. If you see medicines being sold without NAFDAC registration numbers, in packaging that appears altered, at prices that seem anomalous, or by vendors who cannot tell you where they obtained the product, report it to NAFDAC through their official channels, their website, or their nearest zonal office.
Why NAFDAC Cannot Win This Alone
The scale of NAFDAC's enforcement activity across 2025 and 2026 represents a genuine and significant institutional commitment to the problem. The agency is conducting intelligence-led operations, maintaining nationwide enforcement campaigns, issuing specific public alerts, and destroying products at a pace that was rarely achieved in previous years.
But the structural conditions that generate the fake drug trade are not reducible to enforcement intensity alone.
Nigeria's heavy dependence on imports, with about 70 percent of medicines coming from India, China, Pakistan, Egypt, and Indonesia, creates multiple points in the supply chain where diversion, falsification, and substitution can occur. Each handoff in the chain from foreign manufacturer to Nigerian port to licensed importer to wholesaler to retail pharmacy is a point where fake products can be introduced. The longer the chain, the more opportunities for counterfeit insertion.
The departure of major international pharmaceutical manufacturers, specifically the exits of GSK and Sanofi from Nigerian operations, has reduced the availability of some genuine products and increased price pressures that benefit fake drug traders. When legitimate supply contracts, the space for counterfeit supply expands.
The economic conditions that drive demand for cheap medicines are structural. Inflation has made legitimate pharmaceutical products significantly more expensive for millions of Nigerians who are simultaneously facing higher costs for food, fuel, and basic household expenses. Prices for medical products have more than doubled, driving up demand for fake drugs. NAFDAC can destroy seized products, but it cannot eliminate the economic desperation that makes fake drugs attractive to buyers.
The governance of informal markets, including Ariaria in Aba, Idumota in Lagos, and Ogbo-Ogwu in Onitsha, involves complex political and economic relationships that enforcement operations penetrate but do not permanently transform. The same criminal networks that ran fake drug operations in these markets before the recent intensified raids have been operating in them for years, surviving previous enforcement exercises by relocating, restructuring, and restarting.
None of these structural constraints constitutes an argument against vigorous enforcement. They are an argument that vigorous enforcement must be part of a broader policy response that also includes domestic pharmaceutical manufacturing investment, supply chain integrity technology, regulatory reform of informal markets, and sustained public education.
The Antibiotic Resistance Dimension: The Threat That Outlasts the Patient
Fake medicines increase the risk of artemisinin resistance as a result of the use of subtherapeutic dosages of antimalarials. These consequences are more indirect and often ignored or underestimated. Fake products cause the multiplication of false reports on antimalarial resistance and deplete the public's confidence in vital drugs and in the pharmaceutical industry. Large economic losses for legitimate manufacturers demotivate the pharmaceutical industry in producing tropical medicines.
The antimicrobial resistance dimension of the fake drug crisis is the threat that extends beyond the individual patient to the entire population and beyond the present generation to future ones. When a fake antibiotic contains insufficient active ingredient to kill the bacteria it is targeting, those bacteria survive and reproduce. In the process, they develop resistance to the antibiotic compound they have been exposed to. This resistance can spread through bacterial populations, making previously effective treatments useless against infections that they once reliably cured.
Nigeria is already grappling with antimicrobial resistance that has been driven partly by the overuse and misuse of antibiotics. Fake antibiotics represent a specific and compounding driver of resistance, because they expose bacterial populations to subtherapeutic doses of antibiotics continuously across millions of patients, creating exactly the selection pressure under which resistance evolves most rapidly.
The patient who takes a fake antibiotic and recovers, either because their immune system cleared the infection anyway or because the fake product contained some active ingredient, has still contributed to a resistance problem that will affect every patient treated with that antibiotic in the future. The damage of fake drugs is not confined to the individual transaction. It accumulates across populations and across time.
What Must Change: The Structural Response
Protecting Nigerians from fake and expired drugs requires action at multiple levels simultaneously. Individual verification practices, described in detail above, are necessary but not sufficient. The structural conditions that generate and sustain the fake drug trade require structural responses.
Domestic pharmaceutical manufacturing must be expanded. A country that imports 70 percent of its medicines has 70 percent of its pharmaceutical supply subject to the quality and supply chain vulnerabilities of foreign manufacturers and importers. Investment in domestic pharmaceutical manufacturing capacity, both through government incentives and private sector development, would reduce supply chain length, increase oversight opportunities, and reduce the import dependency that creates vulnerability.
Cold chain and supply chain integrity infrastructure must be upgraded. The diversion and degradation of legitimate medicines in transit is enabled partly by inadequate temperature control and track-and-trace infrastructure. Investment in cold chain logistics, RFID tracking of pharmaceutical shipments, and digital supply chain monitoring would close specific vulnerability windows that counterfeiters currently exploit.
Penalties must be commensurate with the crime. The manufacture and distribution of fake medicines is not a victimless economic crime. It is a crime that kills people, some of them children. The legal framework for prosecuting fake drug manufacturers and distributors must treat the activity with the criminal seriousness its consequences demand, including sentences that reflect the harm caused and enforcement that prioritises prosecution over seizure.
Public education about verification must be embedded in health communication. The NAFDAC verification systems, the Greenbook app, the Mobile Authentication Service short code, and the specific red flags described in this article, are tools that exist and work. Getting them into routine use by Nigerian consumers requires sustained, accessible, culturally appropriate public communication that makes verification a reflex rather than an afterthought.
The Bottom Line: What NAFDAC Cannot Do Alone, You Must Do Yourself
Former NAFDAC Director General Prof. Dora Akunyili, who built the agency into a serious regulatory force and survived an assassination attempt by fake drug syndicates for her trouble, described the stakes with characteristic directness: malaria can be prevented, HIV/AIDS can be avoided and armed robbery may kill a few at a time, but fake drugs kill en masse.
She was right then. She is right now.
NAFDAC destroyed over one trillion naira worth of fake and substandard products in the past year. The agency raids warehouses in Lagos, destroys seized products in Awka, issues specific alerts on fake TAVANIC and fake proguanil, and conducts intelligence-led operations that have uncovered industrial repackaging syndicates in Aba. The institutional commitment is real and the operational intensity is the highest it has been in years.
And the fake drugs are still there. Thirty percent of open-market medicines are still fake or substandard. The warehouses keep being replenished. The repackaging machines keep running. The ten million doses seized in February are replaced by ten million doses produced by the networks that were not disrupted.
You cannot wait for enforcement to solve this. The scale of the problem is too large, the supply networks too distributed, and the economic incentives too powerful for any enforcement agency to eliminate the threat through raids alone. What you can do is refuse to be an easy victim.
Verify before you buy. Buy only from licensed pharmacies. Use the NAFDAC Greenbook app. Check the registration number. Inspect the packaging. Be suspicious of low prices. Report suspicious sellers. These are not bureaucratic inconveniences. They are the specific actions that determine whether the medicine you take does what it is supposed to do, or whether it does something entirely different.
Your health, and in some cases your life, depends on whether you treat this as the emergency it is.
Note: This article is for informational and public health education purposes. If you have concerns about a specific medicine, contact NAFDAC directly at their official website, call their consumer protection line, or consult a qualified healthcare professional. Never self-medicate with unverified products.